EUVIMEDEUVIMED entdecken
Open Access

TPST Gene Knock‐Out Eliminates Tyrosine Sulfation on a Recombinant Antibody Produced in CHO Cells

Jacqualyn Schulman iD, Rachel Egan iD, Lakshmi Kandari iD, Nandakumar Madayiputhiya, David Mahon, Li Tao, Hao Luo, Kendall Condon, John N Feder, Dan Huang iD, Anurag Khetan iD

Biotechnology Journal · 2026

DOI: 10.1002/biot.70302 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology Journal, 2026. Verfasst von Jacqualyn Schulman und 10 weiteren Autor:innen. Beteiligte Einrichtung: Biologics Development, Bristol Myers Squibb, Summit, New Jersey, USA. Hauptthemen laut MEDLINE: Tyrosine, Sulfotransferases, Recombinant Proteins, Antibodies, Monoclonal. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tyrosine sulfation is a post‐translational modification that has been reported to occur infrequently on recombinant monoclonal antibodies (mAbs). We recently demonstrated that tyrosine sulfation occurred on a bispecific antibody (bsAb) produced in Chinese hamster ovary (CHO) cells, using a multi‐enzymatic approach in combination with intact mass and peptide‐based mass spectrometry analysis supplemented with the use of synthetic peptides. Tyrosine sulfation needs to be controlled during the manufacturing process due to potential undesired effects, such as impact on potency and immunogenicity. Here, we report that tyrosine sulfation was not significantly inhibited by the addition of chemical inhibitors, such as sodium chlorate. Individual knockout and double knockout (DKO) of two key genes in the tyrosine sulfation pathway were carried out sequentially. Tyrosyl protein sulfotransferase 1/2 (TPST1/2) DKO by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR‐associated protein‐9 nuclease)‐mediated gene editing eliminated tyrosine sulfation while maintaining cell growth, antibody production, and overall product quality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TyrosineSulfotransferasesRecombinant ProteinsAntibodies, MonoclonalAnimalsCHO CellsCricetulusGene Knockout TechniquesProtein Processing, Post-TranslationalCRISPR-Cas SystemsCricetinaeAntibodies, Bispecific

Stichwörter der Autor:innen

CRISPRChinese hamster ovary cellsbiotherapeuticsbispecificpost‐translational modificationproduct quality attributestyrosine sulfation

Substanzen

TyrosineSulfotransferasesRecombinant ProteinsAntibodies, Monoclonalprotein-tyrosine sulfotransferaseAntibodies, Bispecific

Autor:innen und Institutionen

  • Biologics Development, Bristol Myers Squibb, Summit, New Jersey, USA.

ORCID-Profile: Jacqualyn Schulman, Rachel Egan, Lakshmi Kandari, Dan Huang, Anurag Khetan

Zitieren

APA

Schulman, J., Egan, R., Kandari, L., Madayiputhiya, N., Mahon, D., Tao, L., Luo, H., Condon, K., Feder, J. N., Huang, D., & Khetan, A. (2026). TPST Gene Knock‐Out Eliminates Tyrosine Sulfation on a Recombinant Antibody Produced in CHO Cells. Biotechnology Journal. https://doi.org/10.1002/biot.70302

Vancouver

Schulman J, Egan R, Kandari L, Madayiputhiya N, Mahon D, Tao L, et al. TPST Gene Knock‐Out Eliminates Tyrosine Sulfation on a Recombinant Antibody Produced in CHO Cells. Biotechnology Journal. 2026. doi:10.1002/biot.70302

BibTeX
@article{Schulman2026,
  author = {Schulman, Jacqualyn and Egan, Rachel and Kandari, Lakshmi and Madayiputhiya, Nandakumar and Mahon, David and Tao, Li and Luo, Hao and Condon, Kendall and Feder, John N and Huang, Dan and Khetan, Anurag},
  title = {TPST Gene Knock‐Out Eliminates Tyrosine Sulfation on a Recombinant Antibody Produced in CHO Cells},
  journal = {Biotechnology Journal},
  year = {2026},
  doi = {10.1002/biot.70302}
}
Kostenlos starten →